SAB Biotherapeutics annual net debt
2020
2021
2022
2023
2024
2025
SAB Biotherapeutics Net Debt Growth & History (SABS)
SAB Biotherapeutics's net debt was −$4.6M for fiscal 2025.
View full SAB Biotherapeutics company overviewSAB Biotherapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$4.6M | −$47,413 | — |
| 2024 | 2024-12-31 | −$4.5M | $47.2M | — |
| 2023 | 2023-12-31 | −$51.7M | −$41.8M | — |
| 2022 | 2022-12-31 | −$9.9M | $16.6M | — |
| 2021 | 2021-12-31 | −$26.5M | −$21.3M | — |
| 2020 | 2020-12-31 | −$5.2M | — | — |
SAB Biotherapeutics quarterly net debt
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$3.1M | −$5.9M | — |
| Q1 2026 | 2026-03-31 | −$14.3M | −$15.4M | — |
| Q4 2025 | 2025-12-31 | −$4.6M | −$47,413 | — |
| Q3 2025 | 2025-09-30 | −$23.2M | −$18.6M | — |
| Q2 2025 | 2025-06-30 | $2.7M | $15.2M | — |
| Q1 2025 | 2025-03-31 | $1.0M | $10.4M | — |
| Q4 2024 | 2024-12-31 | −$4.5M | $47.2M | — |
| Q3 2024 | 2024-09-30 | −$4.7M | −$6.3M | — |
| Q2 2024 | 2024-06-30 | −$12.5M | −$9.5M | — |
| Q1 2024 | 2024-03-31 | −$9.4M | −$1.4M | — |
| Q4 2023 | 2023-12-31 | −$51.7M | −$41.8M | — |
| Q3 2023 | 2023-09-30 | $1.7M | $4.2M | — |
| Q2 2023 | 2023-06-30 | −$3.0M | $7.6M | — |
| Q1 2023 | 2023-03-31 | −$8.0M | $8.0M | — |
| Q4 2022 | 2022-12-31 | −$9.9M | $16.6M | — |
| Q3 2022 | 2022-09-30 | −$2.6M | — | — |
| Q2 2022 | 2022-06-30 | −$10.6M | — | — |
| Q1 2022 | 2022-03-31 | −$16.0M | — | — |
| Q4 2021 | 2021-12-31 | −$26.5M | — | — |
SAB Biotherapeutics net debt trends
Over the last five fiscal years, SAB Biotherapeutics's net debt increased from −$5.2M to −$4.6M, a change of $642,751. The latest reported quarter, Q2 2026, shows −$3.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SAB Biotherapeutics source filings ↗